Trial Profile
Single ascending dose study of encenicline.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Dec 2015
Price :
$35
*
At a glance
- Drugs Encenicline (Primary)
- Indications Alzheimer's disease; Cognition disorders
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors FORUM Pharmaceuticals
- 07 Dec 2015 New trial record